Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users (original) (raw)
Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia
Fiona Pepper
Psychopharmacology, 2021
View PDFchevron_right
Effects of Ketamine on Anterior Cingulate Glutamate Metabolism in Healthy Humans: A 4-T Proton MRS Study
juan Bustillos
American Journal of Psychiatry, 2005
View PDFchevron_right
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
R. Edden
Molecular Psychiatry, 2012
View PDFchevron_right
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia
Naomi Driesen
JAMA Network Open
View PDFchevron_right
Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers
Lone Baandrup
Frontiers in Psychiatry, 2018
View PDFchevron_right
Clinical and Sensorimotor Gating Effects of Ketamine in Normals
M. Stephanides, Phillip Chappell, Erica Duncan
Neuropsychopharmacology, 2001
View PDFchevron_right
Is Persistent Ketamine Use a Valid Model of the Cognitive and Oculomotor Deficits in Schizophrenia?
Eileen Joyce
Biological Psychiatry, 2009
View PDFchevron_right
Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe
Vasileia Kotoula
Journal of psychopharmacology (Oxford, England), 2015
View PDFchevron_right
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)
Jules Angst
European Neuropsychopharmacology, 1997
View PDFchevron_right
Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics
Allan Clifton
1997
View PDFchevron_right
Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo
Garry Honey
Journal of Neuroscience, 2008
View PDFchevron_right
Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers
Steve Tran
Molecular Psychiatry, 2016
View PDFchevron_right
Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man
Sargo Aalto
Psychopharmacology, 2005
View PDFchevron_right
Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task
francesco musso
Neuroimage, 2011
View PDFchevron_right
Brain damages in ketamine addicts as revealed by magnetic resonance imaging
D. Yew
Frontiers in Neuroanatomy, 2013
View PDFchevron_right
Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia
Diana Limoncelli
Journal of Psychiatric Research, 2015
View PDFchevron_right
Glutamate and Glutamine in the Anterior Cingulate and Thalamus of Medicated Patients With Chronic Schizophrenia and Healthy Comparison Subjects Measured With 4.0-T Proton MRS
Richard Neufeld
American Journal of Psychiatry, 2003
View PDFchevron_right
The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway
Terence O'Brien
Cerebral cortex (New York, N.Y. : 1991), 2016
View PDFchevron_right
Ketamine, at a Dose that Disrupts Motor Behavior and Latent Inhibition, Enhances Prefrontal Cortex Synaptic Efficacy and Glutamate Release in the Nucleus Accumbens
Rene Garcia
Neuropsychopharmacology, 2007
View PDFchevron_right
Psychological effects of ketamine in healthy volunteers
Garry Honey
British Journal of Psychiatry, 2006
View PDFchevron_right
Examination of ketamine-induced deficits in sensorimotor gating and spatial learning
Chelcie Heaney
Physiology & Behavior, 2012
View PDFchevron_right
Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans
FRanz X. Vollenweider
Journal of Psychiatric Research, 2000
View PDFchevron_right
Ketamine-related expression of glutamatergic postsynaptic density genes: Possible implications in psychosis
Daniela Polese, Felice Iasevoli
Neuroscience Letters, 2007
View PDFchevron_right
NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI
Ernst Martin
Schizophrenia Research, 2005
View PDFchevron_right
The Neurobehavioral Pharmacology of Ketamine: Implications for Drug Abuse, Addiction, and Psychiatric Disorders
Cynthia Felix Garcia
ILAR Journal, 2011
View PDFchevron_right
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study
Jaime E. C. Hallak
Archives of general …, 2008
View PDFchevron_right
Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis
Angela Melson
Neuropsychopharmacology, 1999
View PDFchevron_right